This brand name is authorized in Japan, Singapore
The drug UBIT contains one active pharmaceutical ingredient (API):
|
1
Urea ¹³C
UNII W6KX9E6D8X - UREA C-13
|
|
13C-urea is administered in the course of the breath test. After oral ingestion the labelled urea reaches the gastric mucosa. In the presence of Helicobacter pylori the 13C-urea is metabolised by the enzyme urease of Helicobacter pylori. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V04CX05 | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CX Other diagnostic agents | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7290005F1037 |
| Country: SG | Health Sciences Authority | Identifier(s): 13253P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
